Table 3.
Appraisal tool for cross-sectional studies (Downes et al., 2016) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Questions | Tahir et al., 2013 | Kalafat et al., 2016 | Khammash et al., 2005 | Mohseni and Mollas, 2018 | Kumar et al., 2016 | Riccò et al., 2019 | Mehmood et al., 2015 | Tlemissov et al., 2017 | Akman and Kuru al, 2020 |
Were the aims/objectives of the study clear? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Was the study design appropriate for the stated aim(s)? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Was the sample size justified? | No | No | No | No | No | No | No | No | No |
Was the target/reference population clearly defined? (Is it clear who the research was about?) | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Was the sample frame taken from an appropriate population base so that it closely represented the target/reference population under investigation? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Was the selection process likely to select subjects/participants that were representative of the target/reference population under investigation? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Were measures undertaken to address and categorise non-responders? | No | No | No | No | No | No | No | No | No |
Were the risk factor and outcome variables measured appropriate to the aims of the study? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Were the risk factor and outcome variables measured correctly using instruments/measurements that had been trialled, piloted or published previously? | No | No | No | No | No | Yes | Yes | Yes | Yes |
Is it clear what was used to determined statistical significance and/or precision estimates? (e.g. p-values, confidence intervals) | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes |
Were the methods (including statistical methods) sufficiently described to enable them to be repeated? | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes |
Were the basic data adequately described? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Does the response rate raise concerns about non-response bias? | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
If appropriate, was information about non-responders described? | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
Were the results internally consistent? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Were the results presented for all the analyses described in the methods? | No | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes |
Were the authors' discussions and conclusions justified by the results? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Were the limitations of the study discussed? | No | Yes | No | Yes | No | Yes | Yes | Yes | Yes |
Were there any funding sources or conflicts of interest that may affect the authors' interpretation of the results? | No | No | Not reported | Not reported | Not reported | No | Not reported | No | No |
Was ethical approval or consent of participants attained? | Not reported | Not reported | Not reported | Yes | Not reported | Yes | Not reported | Yes | Yes |
Risk of bias assessment | High | Some concerns | High | Some concerns | High | Some concerns | Some concerns | Some concerns | Some concerns |
Appraisal tool for cross-sectional studies (Downes et al., 2016) |
Case series quality appraisal checklist (IHE, 2014) |
||||||||
---|---|---|---|---|---|---|---|---|---|
Questions | Alnasser et al., 2012 | Alsofayan et al., 2022 | Chamari et al., 2012 | Eirale et al., 2013 | Sawaya et al., 2021 | Shanks et al., 1994 | Questions | Kavalci et al., 2013 | Aldoais et al., 2020 |
Were the aims/objectives of the study clear? | Yes | Yes | Yes | Yes | Yes | Yes | Was the hypothesis/aim/objective of the study clearly stated? | Yes | Yes |
Was the study design appropriate for the stated aim(s)? | Yes | Yes | Yes | Yes | Yes | Yes | Was the study conducted prospectively? | Yes | Yes |
Was the sample size justified? | No | No | No | No | No | No | Were the cases collected in more than one centre? | No | Yes |
Was the target/reference population clearly defined? (Is it clear who the research was about?) | Yes | Yes | Yes | Yes | Yes | Yes | Were patients recruited consecutively? | No | No |
Was the sample frame taken from an appropriate population base so that it closely represented the target/reference population under investigation? | Yes | Yes | Yes | Yes | Yes | Yes | Were the characteristics of the patients included in the study described? | Yes | Yes |
Was the selection process likely to select subjects/participants that were representative of the target/reference population under investigation? | Yes | Yes | Yes | Yes | Yes | Yes | Were the eligibility criteria (i.e., inclusion and exclusion criteria) for entry into the study clearly stated? | Yes | Yes |
Were measures undertaken to address and categorise non-responders? | No | No | No | No | No | No | Did patients enter the study at a similar point in the disease? | No | Yes |
Were the risk factor and outcome variables measured appropriate to the aims of the study? | Yes | Yes | Yes | Yes | Yes | Yes | Was the intervention of interest clearly described? | Yes | Yes |
Were the risk factor and outcome variables measured correctly using instruments/measurements that had been trialled, piloted or published previously? | Yes | Yes | Yes | No | Yes | No | Were additional interventions (co-interventions) clearly described? | No | No |
Is it clear what was used to determined statistical significance and/or precision estimates? (e.g. p-values, confidence intervals) | Yes | Yes | Yes | Yes | Yes | No | Were relevant outcome measures established a priori? | Yes | Unclear |
Were the methods (including statistical methods) sufficiently described to enable them to be repeated? | Yes | Yes | Yes | Yes | Yes | No | Were outcome assessors blinded to the intervention that patients received? | No | Unclear |
Were the basic data adequately described? | Yes | Yes | Yes | Yes | Yes | Yes | Were the relevant outcomes measured using appropriate objective/subjective methods? | No | Yes |
Does the response rate raise concerns about non-response bias? | Not reported | Not reported | Not reported | No | Not reported | Not reported | Were the statistical tests used to assess the relevant outcomes appropriate? | Yes | Yes |
If appropriate, was information about non-responders described? | Not reported | Not reported | Not reported | No | Not reported | Not reported | Was follow-up long enough for important events and outcomes to occur? | N/A | Yes |
Were the results internally consistent? | Yes | Yes | Yes | Yes | Yes | Yes | Were losses to follow-up reported? | N/A | No |
Were the results presented for all the analyses described in the methods? | Yes | Yes | Yes | Yes | Yes | No | Did the study provide estimates of random variability in the data analysis of relevant outcomes? | No | No |
Were the authors' discussions and conclusions justified by the results? | Yes | Yes | Yes | Yes | Yes | Yes | Were the adverse events reported? | No | No |
Were the limitations of the study discussed? | Yes | Yes | No | Yes | Yes | No | Were the conclusions of the study supported by results? | Yes | Yes |
Were there any funding sources or conflicts of interest that may affect the authors' interpretation of the results? | No | No | Not reported | No | No | Not reported | Were both competing interests and sources of support for the study reported? | No | No |
Was ethical approval or consent of participants attained? | Yes | Yes | Yes | Yes | Yes | Not reported | |||
Risk of bias assessment | Some concerns | Some concerns | High | Some concerns | Some concerns | Some concerns | High | High |